Ownership history in Squarepoint Ops LLC Β· 6 quarters on record
This page tracks every 13F SEC filing in which Squarepoint Ops LLC reported a position in SANARA MEDTECH INC (SMTI). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price β sourced directly from SEC EDGAR 13F filings.
π Squarepoint Ops LLC underperformed the S&P 500 by β31.8% annually on this SMTI position. Timing score: 20% (1/5 decisions correct). Average cost basis: $28.84. Maximum drawdown during holding period: β29.7%.
β Significantly underperformed the S&P 500 by 31.8% ann.
5 quarters analyzed
β οΈ Poor timing β buys often preceded drops, trims preceded rallies.
1 of 5 add/trim decisions correct
Best entry: $23.35 (2025 Q4) Β· Worst: $33.20 (2024 Q4)
πͺ Held through 1 major drawdown (>20%). Strong conviction under pressure.
5 adds Β· 1 trim. Bought during 2 of 3 down-price quarters. π Consistently bullish β fund kept accumulating this position.
βοΈ Portfolio weight has remained relatively stable β conviction maintained.
Currently 0.0% of portfolio
β Based on quarterly 13F SEC filings and end-of-quarter closing prices. Timing score = accuracy of add/trim decisions vs next-quarter price direction. Alpha = mean quarterly excess return Γ 4 (annualised). Not investment advice.
As of 2025 Q4 β sorted by position size